Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: China-Canada Joint Health Research Initiative

McGill University

$225,000.00

Mechanisms of action of DNA demethylation inhibition as a therapeutic strategy against liver cancer

EF 2010-11

Résumé
Liver cancer is the fifth common cancer in the world and is responsible for 0.5 million yearly deaths in China. There is no cure for liver cancer if detected late but the survival rate is high if it is discovered early. We have previously shown that liver cancer increases expression of thousand of genes in comparison with normal liver and that this process is driven by a loss of the chemical coating of genes by small chemicals called methyl groups. It is impossible to cure cancer by just silencing several genes. It is critical to devise ways to reverse the entire program. This proposal aims to define the ways to reverse the process of loss of methyl groups (demethylation) and thus provide some new avenues for therapy of liver cancer.
Programme
China-Canada Joint Health Research Initiative
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
229020
Name
Szyf Moshe
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
National Natural Science Foundation of China (Haidian, Beijing)
Instname2
Genetics
Theme2
Biomedical
Prcname2
China-Canada Joint Health Research Initiative - Grants Program
Projecttitle
Mechanisms of action of DNA demethylation inhibition as a therapeutic strategy against liver cancer
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$225,000
Cihrequipment2
$0
Programname2
China-Canada Joint Health Research Initiative
Keyworddelim
Dna Methylation; Epigenome; Methylome
Abstract
Liver cancer is the fifth common cancer in the world and is responsible for 0.5 million yearly deaths in China. There is no cure for liver cancer if detected late but the survival rate is high if it is discovered early. We have previously shown that liver cancer increases expression of thousand of genes in comparison with normal liver and that this process is driven by a loss of the chemical coating of genes by small chemicals called methyl groups. It is impossible to cure cancer by just silencing several genes. It is critical to devise ways to reverse the entire program. This proposal aims to define the ways to reverse the process of loss of methyl groups (demethylation) and thus provide some new avenues for therapy of liver cancer.
Competitiondate
201103
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Szyf, Moshe; Sun, Zhongsheng
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Neurosc Mental Hlth &A~ $225,000~ $0~